Journal of Clinical Endocrinology & Metabolism, Vol 73, 1309-1315, Copyright © 1991 by Endocrine Society

ARTICLES

Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer

V Grill, P Ho, JJ Body, N Johanson, SC Lee, SC Kukreja, JM Moseley and TJ Martin
Department of Medicine, St. Vincent's Institute of Medical Research, St. Vincent's Hospital, Fitzroy, Australia.

A RIA for PTH-related protein (PTHrP) is described, using a polyclonal goat antiserum against synthetic PTHrP-(1-40) and recombinant PTHrP-(1- 84) as standard. The detection limit is 2 pmol/L, and intra- and interassay coefficients of variation are 4.8% and 13.6%, respectively. This assay does not detect PTH even at concentrations of up to 2000 pmol/L. Cross-reactivity studies using various synthetic PTHrP peptides localize the antibody-binding epitope between residues 20 and 29. Hypercalcemic patients with a range of solid tumors and no evidence of bone metastases on radionuclide scanning (n = 27) all had detectable PTHrP levels (range, 2.8-51.2 pmol/L). Of 17 patients with solid tumors (other than breast) and bone metastases, 11 (64%) also had detectable PTHrP levels (range, 4.9-47.5 pmol/L). Twenty samples from breast cancer patients with hypercalcemia, 19 with evidence of bone metastases, and 1 with a negative bone scan were assayed, and detectable PTHrP levels were found in 13 (65%; range, 3.8-61.6 pmol/L). Patients with squamous cell carcinomata and normal serum calcium levels (n = 11) had no detectable PTHrP or levels close to the detection limit of the assay (range, less than 2 to 3.7 pmol/L). Plasma levels in normal volunteers were below the detection limit of the assay in all but 1 of 38 normal subjects. Patients with chronic renal failure on hemodialysis (n = 18) and patients with primary hyperparathyroidism (n = 14) all had undetectable PTHrP in this assay. This assay allows positive identification of patients with PTHrP-mediated hypercalcemia and, therefore, should be useful in the clinical investigation of the hypercalcemic patient. Furthermore, it has allowed detection of circulating PTHrP in hypercalcemic breast cancer patients with bone metastases, indicating a significant role for PTHrP in this disease.

This article has been cited by other articles:

				R. O'Dowd, J. C. Kent, J. M. Moseley, and M. E. Wlodek Effects of uteroplacental insufficiency and reducing litter size on maternal mammary function and postnatal offspring growth Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R539 - R548. [Abstract] [Full Text] [PDF]

				R. E. Coleman Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin. Cancer Res., October 15, 2006; 12(20): 6243s - 6249s. [Abstract] [Full Text] [PDF]

				J. P. Woodrow, C. J. Sharpe, N. J. Fudge, A. O. Hoff, R. F. Gagel, and C. S. Kovacs Calcitonin Plays a Critical Role in Regulating Skeletal Mineral Metabolism during Lactation Endocrinology, September 1, 2006; 147(9): 4010 - 4021. [Abstract] [Full Text] [PDF]

				N. Chattopadhyay Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E761 - E770. [Abstract] [Full Text] [PDF]

				M. A. Henderson, J. A. Danks, J. L. Slavin, G. B. Byrnes, P. F.M. Choong, J. B. Spillane, J. L. Hopper, and T. J. Martin Parathyroid Hormone-Related Protein Localization in Breast Cancers Predict Improved Prognosis Cancer Res., February 15, 2006; 66(4): 2250 - 2256. [Abstract] [Full Text] [PDF]

				T. P. Jacobs and J. P. Bilezikian Rare Causes of Hypercalcemia J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6316 - 6322. [Abstract] [Full Text] [PDF]

				G A Clines and T A Guise Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone Endocr. Relat. Cancer, September 1, 2005; 12(3): 549 - 583. [Abstract] [Full Text] [PDF]

				S. Khosla Magic Bullets to Kill Nasty Osteoclasts Endocrinology, August 1, 2005; 146(8): 3233 - 3234. [Full Text] [PDF]

				M. E. Wlodek, K. T. Westcott, R. O'Dowd, A. Serruto, L. Wassef, K. M. Moritz, and J. M. Moseley Uteroplacental restriction in the rat impairs fetal growth in association with alterations in placental growth factors including PTHrP Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1620 - R1627. [Abstract] [Full Text] [PDF]

				J. Tfelt-Hansen, N. Chattopadhyay, S. Yano, D. Kanuparthi, P. Rooney, P. Schwarz, and E. M. Brown Calcium-Sensing Receptor Induces Proliferation through p38 Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase But Not Extracellularly Regulated Kinase in a Model of Humoral Hypercalcemia of Malignancy Endocrinology, March 1, 2004; 145(3): 1211 - 1217. [Abstract] [Full Text] [PDF]

				E. Alvarez, M. Westmore, R. J. S. Galvin, C. L. Clapp, E. L. Considine, S. J. Smith, K. Keyes, P. W. Iversen, D. M. Delafuente, S. Sulaimon, et al. Properties of Bisphosphonates in the 13762 Rat Mammary Carcinoma Model of Tumor-Induced Bone Resorption Clin. Cancer Res., November 15, 2003; 9(15): 5705 - 5713. [Abstract] [Full Text] [PDF]

				J. Tfelt-Hansen, R. J. MacLeod, N. Chattopadhyay, S. Yano, S. Quinn, X. Ren, E. F. Terwilliger, P. Schwarz, and E. M. Brown Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E329 - E337. [Abstract] [Full Text] [PDF]

				J. L. Sanders, N. Chattopadhyay, O. Kifor, T. Yamaguchi, and E. M. Brown Ca2+-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1267 - E1274. [Abstract] [Full Text] [PDF]

				R. M. L. Murray, V. Grill, N. Crinis, P. W. M. Ho, J. Davison, and P. Pitt Hypocalcemic and Normocalcemic Hyperparathyroidism in Patients with Advanced Prostatic Cancer J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4133 - 4138. [Abstract] [Full Text] [PDF]

				J. L. Sanders, N. Chattopadhyay, O. Kifor, T. Yamaguchi, R. R. Butters, and E. M. Brown Extracellular Calcium-Sensing Receptor Expression and Its Potential Role in Regulating Parathyroid Hormone-Related Peptide Secretion in Human Breast Cancer Cell Lines Endocrinology, December 1, 2000; 141(12): 4357 - 4364. [Abstract] [Full Text] [PDF]

				M. E. Wlodek, K. T. Westcott, P. W. M. Ho, A. Serruto, R. Di Nicolantonio, W. Farrugia, and J. M. Moseley Reduced fetal, placental, and amniotic fluid PTHrP in the growth-restricted spontaneously hypertensive rat Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2000; 279(1): R31 - R38. [Abstract] [Full Text] [PDF]

				J.-C. Dumon, T. Jensen, B. Lueddecke, J. Spring, J. Barle, and J.-J. Body Technical and Clinical Validation of an Immunoradiometric Assay for Circulating Parathyroid Hormone-related Protein Clin. Chem., March 1, 2000; 46(3): 416 - 418. [Full Text] [PDF]

				I. J. Diel, E.-F. Solomayer, M. J. Seibel, J. Pfeilschifter, H. Maisenbacher, C. Gollan, M. Pecherstorfer, R. Conradi, G. Kehr, E. Boehm, et al. Serum Bone Sialoprotein in Patients with Primary Breast Cancer Is a Prognostic Marker for Subsequent Bone Metastasis Clin. Cancer Res., December 1, 1999; 5(12): 3914 - 3919. [Abstract] [Full Text] [PDF]

				R. Rizzoli, D. Thiebaud, N. Bundred, M. Pecherstorfer, Z. Herrmann, H. J. Huss, F. Ruckert, C. Manegold, M. Tubiana-Hulin, E. U. Steinhauer, et al. Serum Parathyroid Hormone-Related Protein Levels and Response to Bisphosphonate Treatment in Hypercalcemia of Malignancy J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3545 - 3550. [Abstract] [Full Text] [PDF]

				M. H. C. Lam, L. J. Briggs, W. Hu, T. J. Martin, M. T. Gillespie, and D. A. Jans Importin beta  Recognizes Parathyroid Hormone-related Protein with High Affinity and Mediates Its Nuclear Import in the Absence of Importin alpha J. Biol. Chem., March 12, 1999; 274(11): 7391 - 7398. [Abstract] [Full Text] [PDF]

				N. A. Cross, L. S. Hillman, and L. R. Forte The Effects of Calcium Supplementation, Duration of Lactation, and Time of Day on Concentrations of Parathyroid Hormone-Related Protein in Human Milk: A Pilot Study J Hum Lact, June 1, 1998; 14(2): 111 - 117. [Abstract] [PDF]

				T. A. Guise and G. R. Mundy Cancer and Bone Endocr. Rev., February 1, 1998; 19(1): 18 - 54. [Abstract] [Full Text]

				F. Lepre, V. Grill, P.W.M. Ho, and T.J. Martin Hypercalcemia in Pregnancy and Lactation Associated with Parathyroid Hormone-Related Protein N. Engl. J. Med., March 4, 1993; 328(9): 666 - 667. [Full Text]